MKI67 and breast carcinoma: Although the identification of a single useful cutoff point to define a low and high Ki-67 in all breast cancer patients may not be achievable, the identification of reproducible cutoffs with prognostic and predictive value in specific clinical contexts remains a worthy and active area of investigation.